
    
      The main objective is to demonstrate the beneficial effect of islet allotransplantation in
      patients with type 1 diabetes with no endogenous insulin secretion, and with a functional
      kidney graft. The other objectives are to evaluate the conditions for the efficacy of islet
      cell transplantation, to assess the improvement in quality of life and the cost of the islet
      cell transplantation.
    
  